Pay in 4 interest-free payments of $6.33 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
Phase II clinical trials in humans showed that AOD-9604 produced statistically significant weight loss compared to placebo over 12 weeks
Precipitation or cloudiness If a clear solution later develops cloudiness or visible particles, contamination or degradation has occurred
The peptide stimulates production of VEGF (vascular endothelial growth factor) and HGF (hepatocyte growth factor), both critical for building new capillary networks
Neurocrit Care 44 , 666679 (2026)
US$ 20.35
US$ 27.17
US$ 28.09
